Skip to main content
Fig. 5 | Parasites & Vectors

Fig. 5

From: Efficacy of intranasal LaAg vaccine against Leishmania amazonensis infection in partially resistant C57Bl/6 mice

Fig. 5

In situ cytokine profile in the acute stage of infection. C57Bl/6 mice (from UFF) received 10 μg of LaAg by the intranasal route on days -14 and -7 of infection. Non-vaccinated controls received PBS alone. On day 0, animals were infected with 5 × 105 promastigotes of L. amazonensis (Josefa strain). On day 44 of infection (see Fig. 4), the levels of IFN-γ (a), IL-4 (b), TGF-β (C), IL-10 (d) were measured in the lesion homogenates. The data (means ± standard deviations; n = 4–5) are representative of two independent experiments. *P ≤ 0.05 in comparison to PBS controls (t(6) = 2.491, P = 0.0471)

Back to article page